Found: 28
Select item for more details and to access through your institution.
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1217, doi. 10.1093/neuonc/noac153
- Publication type:
- Article
Reply to Roesler et al. concerning the MEVITEM trial.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1212, doi. 10.1093/neuonc/noac084
- By:
- Publication type:
- Article
relapse doesn't fall far from the radiotherapy field: Lessons to be learned for the future of radiotherapy in medulloblastoma from the relapse patterns of SJMB03.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1176, doi. 10.1093/neuonc/noac082
- By:
- Publication type:
- Article
Resection of glioma—Feeding the beast?
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1088, doi. 10.1093/neuonc/noac078
- By:
- Publication type:
- Article
Reply to "Reporting pediatric brain tumors according to their behavior code can result in biased survival estimates—A European perspective to Girardi et al".
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1208, doi. 10.1093/neuonc/noac077
- By:
- Publication type:
- Article
Targeting adaptive radioresistance in glioblastoma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1071, doi. 10.1093/neuonc/noac074
- By:
- Publication type:
- Article
Enhancing GD2 CAR T-cell therapy with IGF-1R blockade: Are DIPG CAR T cells ready for combinatorial therapy?
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1164, doi. 10.1093/neuonc/noac073
- By:
- Publication type:
- Article
Protons for pediatric ependymoma: Where are we now?
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1203, doi. 10.1093/neuonc/noac066
- By:
- Publication type:
- Article
Infant brain tumor trials: Beyond feasibility.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1191, doi. 10.1093/neuonc/noac065
- By:
- Publication type:
- Article
Opportunities and challenges for the development of "core outcome sets" in neuro-oncology.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1048, doi. 10.1093/neuonc/noac062
- By:
- Publication type:
- Article
Possible mechanisms and biomarkers of resistance to vismodegib in SHH medulloblastoma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1210, doi. 10.1093/neuonc/noac061
- By:
- Publication type:
- Article
Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumors.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1126, doi. 10.1093/neuonc/noac050
- By:
- Publication type:
- Article
Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1074, doi. 10.1093/neuonc/noab302
- By:
- Publication type:
- Article
Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1113, doi. 10.1093/neuonc/noac033
- By:
- Publication type:
- Article
Surveillance imaging frequency in adult patients with lower-grade (WHO Grade 2 and 3) gliomas.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1035, doi. 10.1093/neuonc/noac031
- By:
- Publication type:
- Article
Deuterium magnetic resonance spectroscopy enables noninvasive metabolic imaging of tumor burden and response to therapy in low-grade gliomas.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1101, doi. 10.1093/neuonc/noac022
- By:
- Publication type:
- Article
Clinical reliability of genomic data obtained from spinal metastatic tumor samples.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1090, doi. 10.1093/neuonc/noac009
- By:
- Publication type:
- Article
Reporting pediatric brain tumors according to their behavior code can result in biased survival estimates—A European perspective to Girardi et al.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1205, doi. 10.1093/neuonc/noac039
- By:
- Publication type:
- Article
Evaluation of dose, volume, and outcome in children with localized, intracranial ependymoma treated with proton therapy within the prospective KiProReg Study.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1193, doi. 10.1093/neuonc/noab301
- By:
- Publication type:
- Article
Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1150, doi. 10.1093/neuonc/noab300
- By:
- Publication type:
- Article
Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026).
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1178, doi. 10.1093/neuonc/noab293
- By:
- Publication type:
- Article
Targeting radiation-tolerant persister cells as a strategy for inhibiting radioresistance and recurrence in glioblastoma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1056, doi. 10.1093/neuonc/noab288
- By:
- Publication type:
- Article
Revised clinical and molecular risk strata define the incidence and pattern of failure in medulloblastoma following risk-adapted radiotherapy and dose-intensive chemotherapy: results from a phase III multi-institutional study.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1166, doi. 10.1093/neuonc/noab284
- By:
- Publication type:
- Article
Erratum to: STEM-19. RESISTANCE IS FUTILE: UNDERSTANDING AND TARGETING THE CDK5-CREB1-MCL1 AXIS TO PREVENT RADIATION RESISTANCE IN GLIOMA STEM CELLS.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1216, doi. 10.1093/neuonc/noab070
- By:
- Publication type:
- Article
Erratum to: DDIS-27. TARGETING ATP DOCKING AND P35/P25 BINDING OF CDK5 IN GLIOMA STEM CELLS USING SYNTHETIC INHIBITORS.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1215, doi. 10.1093/neuonc/noab069
- By:
- Publication type:
- Article
Corrigendum to: CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013–2017.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1214, doi. 10.1093/neuonc/noaa269
- By:
- Publication type:
- Article
Corrigendum to: Molecular subgrouping of atypical teratoid/rhabdoid tumors—a reinvestigation and current consensus.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1213, doi. 10.1093/neuonc/noaa210
- By:
- Publication type:
- Article
Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1140, doi. 10.1093/neuonc/noab282
- By:
- Publication type:
- Article